This visit includes a full provider evaluation, InBody body composition scan, symptom review, and protocol design
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Ozempic) and chronic weight management (Wegovy)
No link has been established with denture wearing, chemical or physical trauma, or tobacco use
Neurotransmitter Imbalance in Depression and Its Relation to GLP-1 Neurotransmitters play a cardinal role in the brain and contribute to the regulation of behavior (Lener et al., 2017)
We recommend you bring up any side effects you may be experiencing so we can help get you feeling your best
Starting Your Weight Loss Journey with Medical Supervision Beginning semaglutide treatment requires ongoing medical oversight to ensure optimal results and minimize risks